Pregnancy and childbirth in a woman with homozygous factor V Leiden mutation and thrombosis due to hormonal contraception in a history
- Authors: Khamani N.M.1, Bitsadze V.O.1, Kaplina O.Y.1, Papadakis M.2, Kapanadze D.L.3, Makatsaria A.D.1, Khizroeva J.H.1, Makatsaria N.A.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
- Hospital Papageorgiou
- Center for Pathology of Pregnancy and Hemostasis
- Issue: No 2 (2019)
- Pages: 175-179
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248477
- DOI: https://doi.org/10.18565/aig.2019.2.175-179
- ID: 248477
Cite item
Abstract
Full Text
About the authors
Nadine M. Khamani
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Email: nadinka@list.ru
postgraduate student of the Department of Obstetrics and Gynecology №2
Victoria O. Bitsadze
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Email: gemostasis@mail.ru
MD, professor of the RAS, professor of the Department of Obstetrics and Gynecology №2
Olga Yu. Kaplina
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Email: dr.kaplina@yandex.ru
researcher, Department of Obstetrics and Gynecology №2
Manolis Papadakis
Hospital PapageorgiouMD, professor of the Haematology and Hemostasis Unit Saloniki, Greece
Daredzhan L. Kapanadze
Center for Pathology of Pregnancy and Hemostasis
Email: daka.kapanadze@yandex.ru
PhD, director
Alexander D. Makatsaria
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Email: gemostasis@mail.ru
MD, corresponding member of the RAS, professor, head of the Department of Obstetrics and Gynecology №2
Jamilya H. Khizroeva
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Email: gemostasis@mail.ru
MD, professor of the Department of Obstetrics and Gynecology №2
Natalya A. Makatsaria
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Email: gemostasis@mail.ru
PhD, associate professor of the Department of Obstetrics and Gynecology №2
References
- Beyer-Westendorf J., Bauersachs R., Hach-Wunderle V., Zotz R.B., Rott H. Sex hormones and venous thromboembolism - from contraception to hormone replacement therapy. Vasa. 2018; 47(6): 441-50. doi: 10.1024/0301-1526/ a000726.
- Tricotel A., Raguideau F., Collin C., Zureik M. Estimate of venous thromboembolism and related-deaths attributable to the use of combined oral contraceptives in France. Pant AB, ed. PLoS One. 2014; 9(4): e93792. doi: 10.1371/journal.pone.0093792. eCollection 2014.
- Liatsikos S.A., Tsikouras P., Manav B., Csorba R., von Tempelhoff G.F., Galazio G. Inherited thrombophilia and reproductive disorders. J. Turk. Ger. Gynecol. Assoc. 2016; 17(1): 45-50.
- Tormene D., Grandone E., De Stefano V., Tosetto A., Palareti G., Margaglione M. et al. Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V. Leiden or prothrombin G20210A mutation. Thromb. Haemost. 2012; 107(3): 477-84. doi: 10.1160/TH11-07-0470.
- Peters K., Gordon N., Ricciotti N., Hsieh J., Howard B., Weiss H. Hemostatic effects of two desogestrel-containing combined oral contraceptive regimens: a multinational, multicenter, randomized, open-label study. Clin. Exp. Obstet. Gynecol. 2016; 43(3): 334-40.
- ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to the global disease burden. J. Thromb. Haemost. 2014; 12(10): 1580-9. doi: 10.1111/jth.12698.
- Akinshina S., Makatsariya A., Bitsadze V., Khizroeva J., Khamani N. Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis. J. Perinat. Med. 2018; 46(8): 893-9. doi: 10.1515/jpm-2017-0329.
- Makatsariya A.D., Bitsadze V.O., Khizroeva D.Kh., Akinshina S.V. Thromboprophylaxis in pregnant women with a history of thrombophilia and thromboses. Curr. Prog. Obstet. Gynecol. 2013; 1: 11-23.
- Hugon-Rodin J., Horellou M.H., Conard J., Gompel A., Plu-Bureau G. Type of combined oral contraceptoves, Factor V. Leiden mutation and risk of venous thromboembolism. Thromb. Haemost. 2018; 118(5): 922-8.
- Grimes D.A., Stuart G.S., Levi E.E. Screening women for oral contraception: can family history identify inherited thrombophilias? Obstet. Gynecol. 2012; 120(4): 889-95. doi: 10.1097/AOG.0b013e3182699a2b
- Dragoman M., Curtis K.M., Gaffield M.E. Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes. Contraception. 2016; 94(3): 280-7. doi: 10.1016/j. contraception.2015.08.002.
- Blanco-Molina A. Oral contraception in women with mild thrombophilia: what we have learned recently? Thromb. Res. 2012; 130(Suppl. 1): S16-8. doi: 10.1016/j. thromres.2012.08.263.
- Pezeshkpoor B., Castoldi E., Mahler A., Hanel D., Müller J., Hamedani N.S. et al. Identification and functional characterization of a novel F5 mutation (Ala512Val, FVB onn) associated with activated protein C. resistance. J. Thromb. Haemost. 2016; 14(7): 1353-63. doi: 10.1111/jth.13339.
- Аганезов С.С., Мороцкая А.В., Аганезова Н.В. Экстренная контрацепция: мнения врачей разных специальностей. Акушерство и гинекология. 2017; 4: 137-43.
- Подзолкова Н.М., Колода Ю.А., Коренная В.В., Аксененко В.А., Бакирова Н.Э., Воронцова А.В., Енькова Е.В., Карахалис Л.Ю., Каткова Н.Ю., Минкина Г.Н., Мишарина Е.В., Олина А.А., Сотникова Л.С., Спиридонова Н.В., Ткаченко Л.В., Хачатурян А.Р. Оценка лечебных свойств контрацептивного препарата, содержащего этинилэстрадиол в комбинации с хлормадинона ацетатом. Акушерство и гинекология. 2018; 3: 109-15.
- Дубровина С.О., Берлим Ю.Д. Гестагены в терапии эндометриоза. Акушерство и гинекология. 2018; 5: 150-4.